Research map: GLP-1 receptor agonists and SGLT2 inhibitors in cardiovascular practice: insights from a national survey of French cardiologists.

Back to the article

Papers in this map

  1. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) · Melanie J. Davies · 2022 · 2106 citations · Cited by this paper
  2. Identification and analysis of immunological characteristics of prognostic feature for osteosarcoma based on costimulatory molecule-related genes · 2026 · Related
  3. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association · Chiadi E. Ndumele · 2023 · 2076 citations · Cited by this paper
  4. Negative association between serum lutein/zeaxanthin levels and migraine in American adults: a retrospective study from NHANES · 2026 · Related
  5. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes · Nikolaus Marx · 2023 · 1602 citations · Cited by this paper
  6. TMEM16A contributes to oxLDL-induced macrophage foam cell formation via the p38/JNK MAPK signaling pathways · 2026 · Related
  7. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 · Nuha A. ElSayed · 2022 · 480 citations · Cited by this paper
  8. Serum 25-hydroxyvitamin D levels and Clostridioides difficile-induced enteritis: findings from observational and Mendelian randomization studies · 2026 · Related
  9. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 · Mandeep Singh Bajaj · 2025 · 91 citations · Cited by this paper
  10. Hemoglobin glycation index as a screening tool for aging acceleration and cardiovascular disease: a population-based study · 2026 · Related
  11. Cardiometabolic Medicine: A Call for a New Subspeciality Training Track in Internal Medicine · Robert H. Eckel · 2019 · 40 citations · Cited by this paper
  12. Application of AI-based Machine Learning Integrating Pathomics and Transcriptomics for Diagnosis and Prognostic Prediction in Clear Cell Renal Cell Carcinoma · 2026 · Related
  13. Cardiometabolic Medicine: Development of a New Subspecialty · David R. Saxon · 2020 · 33 citations · Cited by this paper
  14. Patients at high risk of postoperative complications in Crohn’s disease – A meta-analysis and systematic review. · 2026 · Related
  15. Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond · Emir M. Muzurović · 2026 · 20 citations · Cited by this paper
  16. Comparison of ChatGPT and Claude in Managing Real-Life Difficult Nephrology Cases · 2026 · Related
  17. Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease · Niki Katsiki · 2025 · 15 citations · Cited by this paper
  18. Assessment of microbial contamination on mobile phones among medical staff, students, and visitors in a pediatric hematology-oncology ward, and evaluation of its association with nosocomial infections · 2026 · Related
  19. The Cardiac-Kidney-Liver (CKL) syndrome: the “real entity” of type 2 diabetes mellitus · Niki Katsiki · 2024 · 7 citations · Cited by this paper
  20. Cognitive screening for cardiovascular risk stratification in stable coronary artery disease: a prospective cohort study · 2026 · Related
  21. Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients? · Marco Bernardi · 2023 · 5 citations · Cited by this paper
  22. Untitled · Cited by this paper
  23. Untitled · Cited by this paper

Source: OpenAlex (CC0)